Microbot Medical Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: MBOT · Form: 8-K · Filed: Jan 10, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.01, $2.27, $8.6 million, $2.10, $25,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
TL;DR
Microbot Medical inked a big deal and sold some stock.
AI Summary
Microbot Medical Inc. announced on January 7, 2025, that it entered into a material definitive agreement. The company also reported unregistered sales of equity securities and other events. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- January 7, 2025 (date) — Earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19871 (commission_file_number) — SEC File Number
- 94-3078125 (irs_number) — IRS Employer Identification No.
FAQ
What type of material definitive agreement did Microbot Medical Inc. enter into?
The filing states that Microbot Medical Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on January 7, 2025.
What are the key items reported in this 8-K filing?
The key items reported are an entry into a material definitive agreement, unregistered sales of equity securities, other events, and financial statements and exhibits.
Under which section of the Securities Exchange Act is this report filed?
This is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the state of incorporation for Microbot Medical Inc.?
Microbot Medical Inc. is incorporated in Delaware.
Filing Stats: 1,745 words · 7 min read · ~6 pages · Grade level 11.4 · Accepted 2025-01-10 07:45:11
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $2.27 — Common Stock"), at an offering price of $2.27 per share, for aggregate gross proceeds
- $8.6 million — ngs (as defined below) of approximately $8.6 million before deducting the placement agent fe
- $2.10 — es H Warrants") at an exercise price of $2.10 per share. Each Series H Warrant is exe
- $25,000 — Offerings, a non-accountable expense of $25,000, up to $35,000 for its fees and expense
- $35,000 — n-accountable expense of $25,000, up to $35,000 for its fees and expenses of legal coun
- $15,950 — fees and expenses of legal counsel and $15,950 for clearing expenses. The Company has
- $2.8375 — issuance, and have an exercise price of $2.8375 per share. Further, pursuant to the Eng
Filing Documents
- form8-k.htm (8-K) — 53KB
- ex4-1.htm (EX-4.1) — 122KB
- ex4-2.htm (EX-4.2) — 120KB
- ex5-1.htm (EX-5.1) — 13KB
- ex10-1.htm (EX-10.1) — 271KB
- ex99-1.htm (EX-99.1) — 14KB
- ex5-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-001559.txt ( ) — 897KB
- mbot-20250107.xsd (EX-101.SCH) — 3KB
- mbot-20250107_lab.xml (EX-101.LAB) — 33KB
- mbot-20250107_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. /s/ Harel Gadot Harel Gadot Chairman, President and Chief Executive Officer Date: January 10, 2025